BLT 0.00% 10.5¢ benitec biopharma limited

Hep C market - regulus results

  1. 233 Posts.
    lightbulb Created with Sketch. 38
    If you listen to the recent video from regulus CEO (who recently sold a majority of his shares) he uses much of the language peter French does about being a game changing tech. Although I don't see regulus currently being much of a shift from current therapies since they want to couple it with antivirals as well.



    They also experience some minor effects and experienced two relapses.

    http://twitter.com/jq1234t/status/564936207214608384/photo/1

    Be interested in others thoughts
 
GET SUPPORT arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.